Patents by Inventor Haiyan Jia

Haiyan Jia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Live detection system, method, and thermal infrared imager for power grid equipment
    Patent number: 11953379
    Abstract: A live detection system, a thermal infrared (IR) imager and a method for power grid equipment are provided. The system includes an environmental parameter module for acquiring environmental temperature, humidity and wind speed data; a ranging module for measuring a linear distance to the power grid equipment; an equipment type recognition module for acquiring an image of the power grid equipment, and recognizing a type of the power grid equipment; an equipment material determination module for determining a material type of the power grid equipment; an emissivity setting module for setting an emissivity; an temperature measurement module for obtaining a temperature of the power grid equipment by focusing on positions of the power grid equipment which need temperature measurement; and a report generation module for selecting a corresponding diagnostic model, displaying a temperature measurement position and a temperature value, drawing a conclusion, and generating a report.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: April 9, 2024
    Assignees: State Grid Shandong Electric Power Research Institute, State Grid Corporation of China
    Inventors: Rong Liu, Hui Liu, Qinghe Shen, Jinxia Yao, Haiyan Yuan, Bo Yang, Xiaobin Sun, Chao Gu, Ran Jia, Yang Zhang, Chao Zhou, Chuanbin Liu
  • Fusarium head blight resistant gene of wheat and use thereof
    Patent number: 10106815
    Abstract: A Fusarium head blight (FHB) resistant gene Tafhb1 of wheat and uses thereof are disclosed, in which the FHB resistant gene Tafhb1 of wheat has a cDNA sequence as shown in SEQ ID NO. 1. A protein TaFHB1 encoded by the FHB resistant gene Tafhb1 of wheat has an amino acid sequence as shown in SEQ ID NO. 2. The protein includes 274 amino acids, and has an isoelectric point of 10.85. The FHB resistant gene Tafhb1 of wheat is transferred to wheat by crossing and multiple generations of backcrossing, to increase the resistance of wheat to FHB. Because the gene is an endogenous gene existing in the cereal crop wheat, the presence of the gene has no influence on the food safety of plants, such that the gene can be used in crop breeding.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: October 23, 2018
    Assignee: NANJING AGRICULTURAL UNIVERSITY
    Inventors: Zhengqiang Ma, Guoqiang Li, Haiyan Jia, Shulin Xue, Zhongxin Kong, Na Li
  • FUSARIUM HEAD BLIGHT RESISTANT GENE TAFHB1 OF WHEAT AND USE THEREOF
    Publication number: 20170211090
    Abstract: A Fusarium head blight (FHB) resistant gene Tafhb1 of wheat and uses thereof are disclosed, in which the FHB resistant gene Tafhb1 of wheat has a cDNA sequence as shown in SEQ ID NO. 1. A protein TaFHB1 encoded by the FHB resistant gene Tafhb1 of wheat has an amino acid sequence as shown in SEQ ID NO. 2. The protein includes 274 amino acids, and has an isoelectric point of 10.85. The FHB resistant gene Tafhb1 of wheat is transferred to wheat by crossing and multiple generations of backcrossing, to increase the resistance of wheat to FHB. Because the gene is an endogenous gene existing in the cereal crop wheat, the presence of the gene has no influence on the food safety of plants, such that the gene can be used in crop breeding.
    Type: Application
    Filed: January 23, 2017
    Publication date: July 27, 2017
    Applicant: NANJING AGRICULTURAL UNIVERSITY
    Inventors: Zhengqiang MA, Guoqiang LI, Haiyan JIA, Shulin XUE, Zhongxin KONG, Na LI
  • Arginine Derivatives with NP-I Antagonistic Activity
    Publication number: 20120269864
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: June 11, 2012
    Publication date: October 25, 2012
    Inventors: Haiyan Jia, Ian ZACHARY, Michelle TICKNER, Lili CHENG, Chris CHAPMAN, Katie ELLARD, Basil HARTZOULAKIS, Ashley JARVIS, Rosemary LYNCH, Jamie NALLY, David SELWOOD, Mark STEWART
  • NP-1 Antagonists and Their Therapeutic Use
    Publication number: 20120201749
    Abstract: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein: W is arylene, heteroarylene or formula (a) each L is independently alkylene, alkenylene, alkynylene, a direct bond, arylene, cycloalkylene, alkylene-arylene, alkylene-C?O or —C?O; each X is independently an N-containing heteroarylene, N-containing cycloalkylene or NR; Y is N-containing heteroaryl, N-containing cycloalkyl, NR2, OR1, CN or CO2R; Z1 is formula (b); are useful in therapy, particularly in the therapy of neurodegeneration and cancer.
    Type: Application
    Filed: August 25, 2010
    Publication date: August 9, 2012
    Inventors: Melanie Jayne Crawshaw, Philip Spencer Fallon, Ashley Nicholas Jarvis, Jonathan Raymond Powell, Natalie Louise Winfield, David Selwood, Ian Charles Zachary, Haiyan Jia
  • Arginine derivatives with NP-1 antagonistic activity
    Patent number: 8227606
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: July 24, 2012
    Assignee: Ark Therapeutics, Ltd.
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • ARGININE DERIVATIVES WITH NP-I ANTAGONISTIC ACTIVITY
    Publication number: 20120122862
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: January 30, 2012
    Publication date: May 17, 2012
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • Arginine derivatives with NP-I antagonistic activity
    Patent number: 8158789
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: April 17, 2012
    Assignee: Ark Therapeutics Group Ltd.
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • Arginine Derivatives with NP-I Antagonistic Activity
    Publication number: 20100022525
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: October 4, 2007
    Publication date: January 28, 2010
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • VEGF peptides and their use for inhibiting angiogenesis
    Patent number: 7223835
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: May 29, 2007
    Assignee: Ark Therapeutics Ltd.
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Vegf peptides and their use for inhibiting angiogenesis
    Publication number: 20040054143
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 18, 2004
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis